查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541687

按应用分类的吸入一氧化氮市场报告（新生儿呼吸治疗、慢性阻塞性肺病 (COPD)、急性呼吸窘迫症候群 (ARDS) 等）和地区 2024-2032

Inhaled Nitric Oxide Market Report by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球吸入一氧化氮市场规模达9.437亿美元。

吸入一氧化氮 (iNO) 是一种选择性肺血管扩张剂，由三级新生儿加护病房 (NICU) 熟练医生监督。它透过改善通气-灌注不匹配和降低肺血管阻力升高和高血压，有助于调节血管肌张力并治疗新生儿低氧性呼吸衰竭。它还有助于改善氧合併减少对体外膜氧合（ECMO）的需求。目前，越来越多地使用 iNO 疗法作为急性呼吸窘迫症候群 (ARDS) 患者的救援药物。

吸入一氧化氮市场趋势：

新生儿呼吸系统疾病和其他后续疾病（例如持续性肺动脉高压和新生儿缺氧性呼吸衰竭（HRF））的盛行率不断增加，是显着促进市场成长的主要因素之一。此外，相对更容易患高血压、动脉粥状硬化、週边动脉疾病、心臟衰竭和血栓形成的老年人口不断增加，也支持了市场的成长。此外，iNO 在治疗慢性阻塞性肺病 (COPD)、气喘和 ARDS 方面在全球范围内获得了巨大的关注。此外，高度传染性的冠状病毒病（COVID-19）的爆发以及全球范围内感染人数的惊人增加正在对市场产生有利的影响。此外，iNO 疗法也用于对抗冠状病毒感染，因为它有助于改善重症肺炎患者的通气/灌注。该市场也受到世界各地医疗保健行业正在进行的研究和开发（R＆D）活动的​​推动，以改善整体患者体验。

本报告回答的关键问题：

  • 迄今为止，全球吸入一氧化氮市场表现如何，未来几年将如何表现？
  • COVID-19 对全球吸入一氧化氮市场有何影响？
  • 主要区域市场有哪些？
  • 基于应用程式的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球吸入一氧化氮市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球吸入一氧化氮市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按应用

  • 新生儿呼吸治疗
    • 市场趋势
    • 市场预测
  • 慢性阻塞性肺病（COPD）
    • 市场趋势
    • 市场预测
  • 急性呼吸窘迫症候群（ARDS）
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 8 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 9 章：价值链分析

第 10 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 11 章：价格分析

第 12 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Air Liquide SA
    • Bellerophon Therapeutics
    • Beyond Air Inc.
    • Linde plc
    • Mallinckrodt plc
    • Merck KGaA
    • Novoteris LLC
    • Nu-Med Plus
    • VERO Biotech LLC
Product Code: SR112024A4100

The global inhaled nitric oxide market size reached US$ 943.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,657.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.3% during 2024-2032.

Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.

Inhaled Nitric Oxide Market Trends:

The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application.

Breakup by Application:

Neonatal Respiratory Treatment

Chronic Obstructive Pulmonary Disease (COPD)

Acute Respiratory Distress Syndrome (ARDS)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.

Key Questions Answered in This Report:

  • How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global inhaled nitric oxide market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global inhaled nitric oxide market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhaled Nitric Oxide Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Neonatal Respiratory Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acute Respiratory Distress Syndrome (ARDS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Air Liquide S.A
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bellerophon Therapeutics
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
    • 12.3.3 Beyond Air Inc.
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 Linde plc
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
      • 12.3.4.3 Financials
    • 12.3.5 Mallinckrodt plc
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
      • 12.3.5.3 Financials
    • 12.3.6 Merck KGaA
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
      • 12.3.6.3 Financials
      • 12.3.6.4 SWOT Analysis
    • 12.3.7 Novoteris LLC
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Nu-Med Plus
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 VERO Biotech LLC
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhaled Nitric Oxide Market: Major Drivers and Challenges
  • Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2023
  • Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
  • Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
  • Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhaled Nitric Oxide Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 4: Global: Inhaled Nitric Oxide Market: Competitive Structure
  • Table 5: Global: Inhaled Nitric Oxide Market: Key Players